The University of Chicago Header Logo

Connection

Everett Vokes to Tumor Suppressor Protein p53

Back to Details
This is a "connection" page, showing publications Everett Vokes has written about Tumor Suppressor Protein p53.
Everett Vokes
Connection Strength
0.251
Tumor Suppressor Protein p53
  1. MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial. Nat Commun. 2026 Mar 19; 17(1).
    View in: PubMed
    Score: 0.188
  2. Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633. J Thorac Oncol. 2010 Jun; 5(6):810-7.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.